Silverback Therapeutics, Inc.
ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF
Last updated:
Abstract:
Compounds, conjugates and pharmaceutical compositions for use in the treatment of disease, such as cancer, are disclosed herein. The disclosed compounds may be useful, among other things, in treating of cancer and inhibiting ALKS. Compounds incorporated into a conjugate with an antibody construct are also described herein.
Status:
Application
Type:
Utility
Filling date:
2 Apr 2019
Issue date:
27 May 2021